Comparison of toxicity and transfection efficiency of amphiphilic block copolymers and polycationic polymers in striated muscles

Journal of Gene Medicine

Volumn 11, Issue 3, 2009, Pages 240-249

  Roques, Caroline ^a,b,c,d   Fattal, Elias ^c,d   Fromes, Yves ^a,b  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d CNRS   (France)

Author keywords

Amphiphilic copolymers; Gene transfer; Pluronic L64; Polyethyleneimine; Striated muscles; Tetronic 304

Indexed keywords

COPOLYMER; PLASMID DNA; PLURONIC L 64; POLYETHYLENEIMINE; TETRONIC 304; UNCLASSIFIED DRUG; DRUG CARRIER; POLYAMINE; POLYCATIONS; POLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; ELECTROPHORETIC MOBILITY; GENE EXPRESSION; HEART MUSCLE; IN VIVO STUDY; LASER DOPPLER FLOWMETRY; LIGHT SCATTERING; MORPHOLOGY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PH; PLASMID; PRIORITY JOURNAL; SAFETY; SKELETAL MUSCLE; TOXICITY TESTING; TRANSGENE; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CHEMISTRY; CYTOLOGY; EVALUATION; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HAMSTER; MACROMOLECULE; METABOLISM; PARTICLE SIZE; PHYSIOLOGY; SYRIAN HAMSTER;

ANIMALS; CRICETINAE; DRUG CARRIERS; GENE THERAPY; GENETIC VECTORS; MACROMOLECULAR SUBSTANCES; MESOCRICETUS; MUSCLE, STRIATED; MYOCARDIUM; PARTICLE SIZE; PLASMIDS; POLYAMINES; POLYMERS; TRANSFECTION;

EID: 65349175903     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1304     Document Type: Article

References (46)

1. Lu QL, Bou-Gharios G, Partridge TA. Non-viral gene delivery in skeletal muscle: a protein factory. Gene Ther 2003; 10: 131-142.
2. Acsadi G, Dickson G, Love DR, et al. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 1991; 352: 815-818.
3. Cao B, Mytinger JR, Huard J. Adenovirusmediated gene transfer to skeletal muscle. Microsc Res Tech 2002; 58: 45-51.
4. van Deutekom JC, Hoffman EP, Huard J. Muscle maturation: implications for gene therapy. Mol Med Today 1998; 4: 214-220.
5. Fischer A, Cavazzana-Calvo M. Integration of retroviruses: a fine balance between efficiency and danger. PLoS Med 2005; 2: E10.
6. Hartman ZC, Appledorn DM, Amalfitano A. Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications. Virus Res 2008; 132: 1-14.
7. Mingozzi F, High KA. Immune responses to AAV in clinical trials. Curr Gene Ther 2007; 7: 316-324.
8. Raper SE, Chirmule N, Lee FS, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003; 80: 148-158.
9. Boussif O, Lezoualc'h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995; 92: 7297-7301.
10. Demeneix B, Behr J-P. Polyethylenimine (PEI). In Advances in Genetics, Vol. 53. Non-Viral Vectors for Gene Therapy, Huang L, Hung M-C, Wagner E (eds). Academic Press: New York, NY, 2005; 215-230.
11. Roques C, Salmon A, Fiszman MY, et al. Intrapericardial administration of novel DNA formulations based on thermosensitive Poloxamer 407 gel. Int J Pharmaceut2007; 331: 220-223.
12. Lee M, Rentz J, Han SO, et al. Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium. Gene Ther 2003; 10: 585-593.
13. Kang SW, Lim HW, Seo SW, et al. Nanosphere-mediated delivery of vascular endothelial growth factor gene for therapeutic angiogenesis in mouse ischemic limbs. Biomaterials 2008; 29: 1109-1117.
14. Türk M, Dinçer S, Piskin E. Smart and cationic poly (NIPA)/ PEI block copolymers as non-viral vectors: in vitro and in vivo transfection studies. J Tissue Eng Regen Med 2007; 1: 377-388.
15. Lemieux P, Guerin N, Paradis G, et al. A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene Ther 2000; 7: 986-991.
16. Pitard B, Bello-Roufai M, Lambert O, et al. Negatively charged self-assembling DNA/poloxamine nanospheres for in vivo gene transfer. Nucleic Acids Res 2004; 32: E159.
17. Pitard B, Pollard H, Agbulut O, et al. A nonionic amphiphile agent promotes gene delivery in vivo to skeletal and cardiac muscles. Hum Gene Ther 2002; 13: 1767-1775.
18. Richard P, Bossard F, Desigaux L, et al. Amphiphilic block copolymers promote gene delivery in vivo to pathological skeletal muscles. Hum Gene Ther 2005; 16: 1318-1324.
19. Richard P, Pollard H, Lanctin C, et al. Inducible production of erythropoietin using intramuscular injection of block copolymer/DNA formulation. J Gene Med 2005; 7: 80-86.
20. Yang Z, Zhu J, Sriadibhatla S, et al. Promoter- and strainselective enhancement of gene expression in a mouse skeletal muscle by a polymer excipient Pluronic P85. J Control Release 2005; 108: 496-512.
21. Chiappetta DA, Sosnik A. Poly (ethylene oxide)-poly (propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs. Eur J Pharm Biopharm 2007; 66: 303-317.
22. Kabanov A, Zhu J, Alakhov V. Pluronic block copolymers for gene delivery. Adv Genet 2005; 53: 231-261.
23. Dong J, Armstrong J, Chowdhry BZ, et al. Thermodynamic modelling of the effect of pH upon aggregation transitions in aqueous solutions of the poloxamine, T701. Thermochimica Acta 2004; 417: 201-206.
24. Alvarez-Lorenzo C, Gonzalez-Lopez J, Fernandez-Tarrio M, et al. Tetronic micellization, gelation and drug solubilization: Influence of pH and ionic strength. Eur J Pharm Biopharm 2007; 66: 244-252.
25. Dong J, Chowdhry BZ, Leharne SA. Surface activity of poloxamines at the interfaces between air-water and hexane-water. Colloids Surf A Physicochem Eng Asp 2003; 212: 9-17.
26. Prokop A, Kozlov E, Moore W, et al. Maximizing the in vivo efficiency of gene transfer by means of nonviral polymeric gene delivery vehicles. J Pharm Sci 2002; 91: 67-76.
27. Schmolka IR. Artificial skin I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res 1972; 6: 571-582.
28. Fromes Y, Salmon A, Wang X, et al. Gene delivery to the myocardium by intrapericardial injection. Gene Ther 1999; 6: 683-688.
29. Dunlap DD, Maggi A, Soria MR, et al. Nanoscopic structure of DNA condensed for gene delivery. Nucleic Acids Res 1997; 25: 3095-3101.
30. Neu M, Fischer D, Kissel T. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med 2005; 7: 992-1009.
31. Goula D, Remy JS, Erbacher P, et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther 1998; 5: 712-717.
32. Sharma VK, Thomas M, Klibanov AM. Mechanistic studies on aggregation of polyethylenimine-DNA complexes and its prevention. Biotechnol Bioeng 2005; 90: 614-620.
33. Ogris M, Brunner S, Schuller S, et al. PEGylated DNA/ transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 1999; 6: 595-605.
34. Kircheis R, Schuller S, Brunner S, et al. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J Gene Med 1999; 1: 111-120.
35. Wang J, Zhang PC, Mao HQ, et al. Enhanced gene expression in mouse muscle by sustained release of plasmid DNA using PPE-EA as a carrier. Gene Ther 2002; 9: 1254-1261.
36. Anderson DG, Peng W, Akinc A, et al. A polymer library approach to suicide gene therapy for cancer. Proc Natl Acad Sci USA 2004; 101: 16028-16033.
37. Bertschinger M, Backliwal G, Schertenleib A, et al. Disassembly of polyethylenimine-DNA particles in vitro: implications for polyethylenimine-mediated DNA delivery. J Control Release 2006; 116: 96-104.
38. Carpentier E, Paris S, Kamen AA, et al. Limiting factors governing protein expression following polyethylenimine-mediated gene transfer in HEK293-EBNA1 cells. J Biotechnol 2007; 128: 268-280.
39. Hama S, Akita H, Ito R, et al. Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems. Mol Ther 2006; 13: 786-794.
40. Varga CM, Tedford NC, Thomas M, et al. Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes. Gene Ther 2005; 12: 1023-1032.
41. Gau-Racine J, Lal J, Zeghal M, et al. PEO-PPO block copolymer vectors do not interact directly with DNA but with lipid membranes. J Phys Chem B 2007; 111: 9900-9907.
42. Tang MX, Szoka FC. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther 1997; 4: 823-832.
43. Bochot A, Fattal E, Gulik A, et al. Liposomes dispersed within a thermosensitive gel: a new dosage form for ocular delivery of oligonucleotides. Pharm Res 1998; 15: 1364-1369.
44. Kabanov AV, Lemieux P, Vinogradov S, et al. Pluronic block copolymers: novel functional molecules for gene therapy. Adv Drug Deliv Rev 2002; 54: 223-233.
45. Yurchenco PD. Assembly of basement membranes. Ann NY Acad Sci 1990; 580: 195-213.
46. Emerson CP, Hauschka SD. Embryonic origins of skeletal muscles. In Myology, Engel AG, Franzini-Armstrong C (eds). McGraw-Hill: New-York, NY, 2004; 3-44.